Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production
- 15 December 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (13) , 4537-4543
- https://doi.org/10.1182/blood-2002-05-1525
Abstract
CD5 is a negative regulator of B-cell receptor (BCR) signaling that is up-regulated after BCR stimulation and likely contributes to B-cell tolerance in vivo. However, CD5 is constitutively expressed on the B-1 subset of B cells. Contrary to CD5− B-2 B cells, B-1 B cells are long-lived because of autocrine interleukin-10 (IL-10) production through unknown mechanisms. We demonstrate herein a direct relationship between CD5 expression and IL-10 production. Human peripheral blood CD5+ B cells produce more IL-10 than CD5− B cells after BCR activation. Introducing CD5 into CD5− B cells induces the production of IL-10 by activating its promoter and the synthesis of its mRNA. The cytoplasmic domain of CD5 is sufficient for this process. CD5 also protects normal human B cells from apoptosis after BCR stimulation while reducing the BCR-induced Ca2+ response. We conclude that CD5 supports the survival of B cells by stimulating IL-10 production and by concurrently exerting negative feedback on BCR-induced signaling events that can promote cell death.Keywords
This publication has 30 references indexed in Scilit:
- De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patientsBlood, 2002
- Interaction of the CD5 cytoplasmic domain with the Ca2+ /calmodulin-dependent kinase IIδEuropean Journal of Immunology, 1998
- Regulation of Casein Kinase 2 by Direct Interaction with Cell Surface Receptor CD5Published by Elsevier ,1998
- CD5-Mediated Negative Regulation of Antigen Receptor-Induced Growth Signals in B-1 B CellsScience, 1996
- Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.Journal of Clinical Investigation, 1996
- Episomal Vectors Rapidly and Stably Produce High-Titer Recombinant RetrovirusHuman Gene Therapy, 1996
- Signals and susceptibility to programmed death in B cellsCurrent Opinion in Immunology, 1996
- Treatment of murine CD5− B cells with anti-lg, but not LPS, induces surface CD5: two B-cell activation pathwaysInternational Immunology, 1991
- Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1989
- Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1982